The Brooklyn-based company has developed technology to identify and quantify 5-hydroxymethylcytosine, which was only identified in mammals a year ago and has been elusive to detection.
A bill passed by a US House of Representatives appropriations subcommittee would give scientific agencies including the National Science Foundation boosts in funding.
